论文信息 - Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. - 字舞流文

Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.

P. Maslak | J. Werner | G. Schwartz | L. Saltz | P. Maslak | D. Kelsen | W. Tong | E. O’Reilly | D. Ilson | D. Ilson | M. Stoltz | P. Perkins | Jeanine Werner | Pam Perkins